Patients’ experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07407.x/fullpdf
Reference25 articles.
1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993
2. A substantive theory of quality of life of adults with chronic leukaemia;Bertero;International Journal of Nursing Studies,1997
3. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial;Catovsky;Lancet,2007
4. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy;Coates;European Journal of Cancer,1997
5. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group;Eichhorst;Journal of Clinical Oncology,2007
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health‐related quality of life in older hematological cancer survivors (70+) compared to older general population—A German cancer‐register‐based cross‐sectional comparative study;European Journal of Haematology;2024-08
2. Health-related quality of life in adults with hematological cancer: a 2023 cross-sectional survey from Qatar;Frontiers in Oncology;2024-05-28
3. Patient-reported distress and problems among elderly patients with hematological malignancy in Korea;Supportive Care in Cancer;2022-08-10
4. Quality of life of patients with hematological malignancies and factors affecting health state utility values;Supportive Care in Cancer;2022-03-12
5. Muscle Mass, Cachexia, and Health-Related Quality of Life in Patients with Hematologic Malignancies;Physical Therapy and Research in Patients with Cancer;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3